This report describes the use of counterelectrophoresis as a sensitive, reliable, and easy method of detecting fibrinogen-fibrin degradation products (FDP) . Because the effects of these materials may be deleterious their recognition is important and, therefore, multiple techniques have been devised to delineate their presence. Certain of these procedures, such as the tanned red cell haemagglutination inhibition assay (Merskey, Lalezari, and Johnson, 1969) and the staphylococcal clumping test (Hawiger, Niewiarowski, Gurewich, and Thomas, 1970) , have a high degree of sensitivity but the manner in which they are carried out, their complexity, and the reagents they require often limit their availability to highly specialized laboratories. In contrast, counterelectrophoresis, performed under optimal conditions as described, has neither of these drawbacks and maintains the desirable feature of permitting detection of FDP generated by a number of mechanisms in a variety of clinical conditions.
Methods

PATIENTS
Tests for FDP were performed on three classes of individuals. The first included 15 actively bleeding patients. Eight of these had septicaemia and developed auxiliary evidence of disseminated intravascular coagulation. The remainder were patients with cirrhosis whose clinical symptom complex, hospital course, and associated laboratory data supported the diagnosis of primary fibrinolysis. The 'Supported, in part, by USPHS research grant CA 07000. 'Recipient of USPHS research career development award 5KI CA8371.
Received for publication 16 June 1972. second group of 39 patients had a multiplicity of disorders or states each of which, inherently and potentially (Deykin, 1970) , could lead to the development of FDP. In this category were seven healthy, asymptomatic females taking oral contraceptives; 10 immediately postoperative patients (surgical procedures represented were lobectomy, cholecystectomy, prostatectomy, gastrectomy, dilatation and curettage, meniscus repair, and cystoscopy); two patients with metastatic gastric adenocarcinoma; eight patients with disorders of haematopoiesis (included were multiple myeloma, chronic lymphocytic leukaemia, sicklaemia, erythremic myelosis, and polycythaemia vera); 12 patients with miscellaneous diseases (von Willebrand's disease, Felty's syndrome, acute proliferative glomerulonephritis, chronic pyelonephritis, vitamin K deficiency, rheumatoid arthritis, diabetes mellitus, viraemia, mitral valve prosthesis, and coronary artery disease). Finally, studies were also performed on 11 completely healthy normal volunteers from the hospital's professional and technical staffs. Thus, there were 65 participants in the project.
TESTS FOR FDP
Using a discontinuous buffer system (Alter, Holland, and Purcell, 1971) , counterelectrophoresis was carried out on ordinary 1 x 3 inch microscope slides precoated with 1-5% agarose (Calbiochem, Los Angeles, Calif) in distilled water and dried at 37°C. To prepare supporting templates, four slides were placed in a 15 cm diameter Petri dish which contained a solidified 3 mm agarose gel layer formed previously to provide a perfectly level surface (Brody, Mobarak, and Haidar, 1967 (Marder, Matchett, and Sherry, 1971) .
Results
The results of all the tests for FDP are summarized in the Table. Counterelectrophoresis detected degradation products in all 15 actively bleeding patients and always beyond undiluted serum (Fig. 1A) (Marder et al, 1971) but is less cumbersome to perfolm and does not require preparation and storage of special reagents. While there is no intention to indicate that counterelectrophoresis should supplant present techniques now employed in the study of patients with this form of clotting abnormality, its ready availability, sensitivity, and facility of performance using conventional equipment, should make it a valuable and reliable addition to any laboratory with the responsibility for detecting fibrinogen-fibrin degradation products.
